Thermo Fisher Precision Oncology Seminar
Accelerating oncology translational research with targeted next generation sequencing
About This EventAdvances in targeted next-generation sequencing have been instrumental in quickening the pace of discovery in oncology and translational research.
In fact, targeted next generation sequencing allows for the ability to analyze only the genes of interest in a rapid, cost-effective manner and thus has the potential to transform the strategies and workflow of oncology research.
Join Q2 Solutions at the Thermo Fisher Precision Oncology Seminar, where Stephanie Hastings, Q2 Solutions, will be leading a discussion on Targeted Genomic Profiling using Ion Oncomine Comprehensive Assays.
Address: 15 T.W. Alexander Drive, Research Triangle Park, NC 27709
Room: Glaxo Galleria Room
We look forward to seeing you there!
Scientist, Assay Development, Translational Genomics
Stephanie B. Hastings, Ph.D., is an assay development scientist in Translational Genomics at Q2 Solutions | EA Genomics. In this role, she is responsible for the development and validation of genomic assays to support research and clinical programs. Stephanie is currently leading development efforts surrounding liquid biopsy applications, including circulating-tumor DNA (ctDNA) and circulating-tumor cells (CTCs).
Stephanie has more than 10 years of experience across diverse disciplines including: clinical molecular diagnostics, animal health vaccine development, genetic engineering and protein biochemistry.
Stephanie earned a Bachelors degree in Microbiology from North Carolina State University, followed by a Ph.D. in Biochemistry and Molecular Biology at the University of Georgia.
Updated as of September 2018.